MCCORMICK FRANK bought BBOT
June 16, 2026 · Form 4 insider transaction
MCCORMICK FRANK bought 31,675 shares of BridgeBio Oncology Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,675
Price
$0.00
Total value
N/A
InsiderMCCORMICK FRANK
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 16, 2026
Filing dateJune 18, 2026
Shares owned after31,675
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying the stock option vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting of Stockholders of the Issuer following the date of grant, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.